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The Healthy People 2020 Roadmap for Massachusetts Children & Youth with ASD/DD  
Understanding Needs and Measuring Outcomes 
Elaine Gabovitch, MPA, Courtney Dutra, MPA & Emily Lauer, MPH 
University of Massachusetts-Eunice Kennedy Shriver Center 
Background:  
The Massachusetts Autism Commission 2012 report identified “a critical 
need to develop a comprehensive statewide approach” to respond to the 
needs of the rapidly increasing population of people with autism spectrum 
disorder and developmental disabilities (ASD/DD). In response, the 
UMMS-Shriver Center has been conducting a needs assessment to inform 
efforts to establish a state-level data collection and surveillance plan for 
systems of services for children and youth with ASD/DD.  
 
Methods:  
The project’s objectives are to:  
(1) Assess state needs of children with ASD and DD that align with six 
MCHB core indicators (i.e., early identification, medical home, access 
to community-based systems of care, family involvement, transition to 
adulthood, and insurance);  
(2) Make recommendations to refine the existing Massachusetts Autism 
Commission plan and address identified needs; and  
(3) Outline an ongoing surveillance strategy to monitor and report on 
future state ASD/DD outcomes.  
 
This project has focused on understanding several factors including race, 
culture, language, region, level of function, and mental health.  
 
Preliminary Findings:  
Although Massachusetts is a resource rich state, through a review of 
secondary data analysis, key informant interviews, focus groups, and 
surveys, the needs assessment has identified certain gaps in services and 
coverage. Selected findings are shared here, though much more exists. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Insurance Utilization 
 
• Universal healthcare (2006)  
• 96% insured/4% uninsured; however pockets (immigrants, minorities) of 
uninsured with sharp contrasts between socio-economic areas 
(e.g., East Boston: 23.7%; New Bedford: 22.1%; 10 affluent census tracts in MA: 0%)  
• Autism-specific coverage: 
• ARICA law (2011) applies to private, state-regulated plans 
• Diagnosis and treatment of ASD (ABA, speech, etc.); no $ limit, no age limit 
• Habilitative, rehabilitative, pharmacy, psychiatric, psychological, therapeutic 
• MassHealth in the process of expanding coverage (<21) 
• ERISA plans federally regulated and exempt from state law 
• UMMS-Shriver Autism Insurance Resource Center assists families and 
providers with information on insurance coverage in MA (3,000+ contacts) 
• Home & Community-based Waiver expansion for children with ASD & ID 
 
Accessible community-based service system 
• Psychotropic Medication use 
• MassHealth recently instituted prior authorization rules for children, based 
on recent GAO report, e.g. inter- and intra-class polypharmacy 
• At least 1/3 children with flagged prescription profiles had utilization claims 
with ASD diagnoses 
• Challenges with coordination of care; talks on strategies with MA Children’s 
Behavioral Health Initiative 
 
Transition to Adult Health Care 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Funding: Health Resources & Services Administration-Maternal & Child Health Bureau 
Early Identification 
 
• Trends in ASD by age 36 months and identified characteristics 
associated with early diagnoses in MA (Manning et al, 2011): 
 
• Rate of early diagnoses: Increased 66% from 2001 - 2005 
• Incidence: 1 in 178 (2001); 1 in 108 (2005); 1 in 85 (2013); 1 in 78 
(2015)  
• Average age of diagnosis for children in EI:  2.56 years old 
 
• Cultural/linguistic gap:  
• Infants of mothers whose primary language was not English or were 
foreign-born had lower odds of an early ASD diagnosis   
• May reflect groups with greater barriers to early screening  
 
• Shrinking racial gap:  
• 2001: lower rates of early ASD diagnoses in racial minorities 
• 2005: racial differences substantially lessened.   
• Suggests screening improved among racial minorities 
Results 
DBP Clinics (n=26) Pediatricians (n=106) 
Top reasons  late 
referral: 
Parents unaware of 
milestones/red flags (77%) 
Parents unaware of 
milestones/red flags (88%) 
Primary language not English 
(59%) 
Primary language not English 
(61%) 
Limited caregiver ability (55%) Limited caregiver ability (62%) 
Lower SES (44%) Lower SES (60%) 
% non-English 
speaking patients: 
<25%      = 81% 
25-50%  = 12% 
51-75%  = 4% 
<20%     = 61% 
21-50% = 24% 
51-80% = 13% 
I have access to: Interpreters              = 58% 
Translators                = 23% 
Cultural liaisons       = 15% 
Bilingual providers  =  15% 
Interpreters             = 93% 
Translators               = n/a 
Cultural liaisons      = 9% 
Bilingual providers =  40% 
I do not have access 
to language services: 
35% N/A 
What do you do 
when patient’s family 
does not speak 
English? 
Re: Evaluation: 
Use translated measure (23%) 
Perform w/ interpretation 
(62%)  
Do not evaluate (35%) 
Re: Screening: 
Use translated measure (45%) 
Perform w/ interpretation 
(70%) 
Do not screen (20%) 
2 to 12 mos. 
(median 5 mos.) 
>1 to over 12 mos. 
(median 2 mos.) 
>1 to 9 mos. 
(median 3 mos.)  
>1 to 6 mos. 
(median 3 mos.) 
>1 to 6 mos. 
(median 3 mos.) 
Transition to Adult Health Care  
(NS-CSHCN, 2010) 
MA % or # U.S. % or # 
YSHCN who received services to transition 47% 40% 
Hispanic 35% 25% 
Black, non-Hispanic 20% 28% 
Other, non-Hispanic 35% 40% 
White, non-Hispanic 51% 46% 
Wait Time Survey 
In Their 
Own Words 
Discussion 
“My biggest concern is 
the vast difference 
money makes. For low 
income families, so few 
providers take 
MassHealth.” 
“In our programs, 50% of 
people referred to local 
medical centers for an Autism 
evaluation don’t show up. 
With the use of family 
navigators, that number 
increases to 90%.” 
“80% of the IEP’s I 
read appear to have 
been translated by 
Google Translate. The 
translation is not very 
good or very clear.” 
“The biggest problem is 
that the folks doing 
transition for your child 
have no idea what adult 
services look like…And 
so folks don’t really know 
what they are going to 
get.”  
“We see a lot of homeless 
families and they are just 
trying to get by. They need 
the diagnosis, but where they 
are living is horrendous. But 
they need that outreach to 
prioritize the services they 
need.”  
Through a triangulated data review to examine state strengths and needs in 
the six Healthy People 2020 core indicator areas of early identification, 
medical home, access to community-based systems, family involvement, 
insurance and transition, preliminary findings indicate that while 
Massachusetts has done well in such areas as lowering the average age of 
identification, instituting universal insurance coverage, and offering resources 
and services that support children and youth with ASD/DD and their families, 
its challenges now lie in addressing barriers by region, socio-economics, 
mental health, and culture, race and language. Old data systems need 
updating.  Providers may not take Medicaid.  Essential therapies like ABA 
need more therapists. Access to the All Payer Claims Database, which has just 
released its 3.0 version, is needed to better understand healthcare access and 
outcomes. The future  will lie in sharing our findings with the Commission and 
diverse communities to work on the most meaningful solutions together. 
